↓ Skip to main content

Aspirin in COVID-19: Pros and Cons

Overview of attention for article published in Frontiers in Pharmacology, March 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

twitter
43 X users

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Aspirin in COVID-19: Pros and Cons
Published in
Frontiers in Pharmacology, March 2022
DOI 10.3389/fphar.2022.849628
Pubmed ID
Authors

Rana Zareef, Marwa Diab, Tala Al Saleh, Adham Makarem, Nour K. Younis, Fadi Bitar, Mariam Arabi

X Demographics

X Demographics

The data shown below were collected from the profiles of 43 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 13%
Researcher 3 10%
Student > Ph. D. Student 2 7%
Student > Bachelor 2 7%
Other 1 3%
Other 3 10%
Unknown 15 50%
Readers by discipline Count As %
Medicine and Dentistry 4 13%
Biochemistry, Genetics and Molecular Biology 3 10%
Nursing and Health Professions 2 7%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Environmental Science 1 3%
Other 4 13%
Unknown 15 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2024.
All research outputs
#1,643,214
of 26,523,931 outputs
Outputs from Frontiers in Pharmacology
#666
of 20,594 outputs
Outputs of similar age
#38,788
of 454,223 outputs
Outputs of similar age from Frontiers in Pharmacology
#39
of 1,246 outputs
Altmetric has tracked 26,523,931 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,594 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 454,223 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 1,246 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.